Taken together, these results show that synergy of FAAH inhibitors with ferroptosis inducers significantly inhibits RCC tumor growth and metastasis, which demonstrates that targeting both FAAH and ferroptosis could be a promising therapeutic approach to treating RCC. This evidence concerns the gene FAAH and neoplasm.